» Articles » PMID: 29439311

Overexpression of YTHDF1 is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma

Overview
Journal Cancer Biomark
Publisher Sage Publications
Specialties Biochemistry
Oncology
Date 2018 Feb 15
PMID 29439311
Citations 150
Authors
Affiliations
Soon will be listed here.
Abstract

In China, hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer and the leading cause of cancer death in men, followed by lung and stomach cancer. There was an urgent need to identify novel prognostic biomarkers for HCC. We explored the expression pattern of m6A related proteins in HCC tissues by using TCGA in this study. We found that the m6A 'reader' YTHDF1 was significantly upregulated in HCC and was positive correlated with pathology stage. Kaplan-Meier analysis showed that Lower YTHDF1 expression level was associated with better survival of HCC patients. Furthermore, we performed GO and KEGG pathway analysis of YTHDF1 co-expressed genes and found YTHDF1 played an important role in regulating HCC cell cycle progression and metabolism. We believed that this study will provide a potential new therapeutic and prognostic target for HCC.

Citing Articles

WTAP regulates Mitochondrial damage and Lipid oxidation in HCC by NOA1 mediated m6A modification.

Liu S, Shang M, Gong J, Sun H, Hu B J Cancer. 2025; 16(1):315-330.

PMID: 39744575 PMC: 11660133. DOI: 10.7150/jca.102618.


Detecting the Tumor Prognostic Factors From the YTH Domain Family Through Integrative Pan-Cancer Analysis.

Zhu C, Yang Q, Mu X, Zhai Y, Zhao W, Yin Z Cancer Inform. 2024; 23:11769351241300030.

PMID: 39553336 PMC: 11569503. DOI: 10.1177/11769351241300030.


YTHDF1 gene inhibits epilepsy progression by epigenetic activation of PTEN gene.

Li M, Yang J, Gao L Heliyon. 2024; 10(20):e39481.

PMID: 39497959 PMC: 11533598. DOI: 10.1016/j.heliyon.2024.e39481.


The Role of m6A Methylation in Tumor Immunity and Immune-Associated Disorder.

Mu S, Zhao K, Zhong S, Wang Y Biomolecules. 2024; 14(8).

PMID: 39199429 PMC: 11353047. DOI: 10.3390/biom14081042.


Roles of N6-methyladenosine epitranscriptome in non-alcoholic fatty liver disease and hepatocellular carcinoma.

Chen Y, Zhu Z, Zhang L, Wang J, Ren H Smart Med. 2024; 2(3):e20230008.

PMID: 39188344 PMC: 11235706. DOI: 10.1002/SMMD.20230008.